miRNA genetic alterations in human cancers - PubMed (original) (raw)
Review
miRNA genetic alterations in human cancers
Antonis Giannakakis et al. Expert Opin Biol Ther. 2007 Sep.
Abstract
MicroRNAs (miRNAs) are endogenous, non-coding, small RNAs, which negatively regulate gene expression in a sequence-specific manner via translational repression and/or mRNA degradation. Their discovery revealed a new and exciting aspect of post-transcriptional gene regulation that is universally involved in cellular homeostasis. Importantly, the advent of miRNAs added another level of complication in the already complex regulatory networks of the cell, undermining that RNA molecules in general, should be considered gene regulators of equal importance with proteins. Recently, the scientific community drew attention to the miRNA field for an additional reason: an increasing line of evidence indicated that miRNA genes are tightly connected with the process of tumorigenesis. Indeed, several miRNAs have already been demonstrated to behave as oncogenes or tumor suppressor genes in many types of cancer. Even though the underlying mechanisms by which miRNAs can destabilize the normal cellular processes, promoting cell transformation and tumor progression, are not well understood, genetic and epigenetic alterations most probably play a critical role. Significant technologic advances facilitated the profiling of the miRNA expression patterns in normal and cancer tissues and discovered an unexpected greater reliability of miRNA expression signatures in classifying cancer types than the respective signatures of protein-coding genes. Along with this extraordinary diagnostic potential, miRNAs have also proved their prognostic value in predicting clinical behaviors of cancer patients. The aim of this review is to describe miRNA expression and how its deregulation is involved in the pathophysiology of human cancers.
Similar articles
- MicroRNAs in human cancer: from research to therapy.
Negrini M, Ferracin M, Sabbioni S, Croce CM. Negrini M, et al. J Cell Sci. 2007 Jun 1;120(Pt 11):1833-40. doi: 10.1242/jcs.03450. J Cell Sci. 2007. PMID: 17515481 - microRNAs as oncogenes and tumor suppressors.
Zhang B, Pan X, Cobb GP, Anderson TA. Zhang B, et al. Dev Biol. 2007 Feb 1;302(1):1-12. doi: 10.1016/j.ydbio.2006.08.028. Epub 2006 Aug 16. Dev Biol. 2007. PMID: 16989803 Review. - MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K, Fang X, Ouyang G. Ruan K, et al. Cancer Lett. 2009 Nov 28;285(2):116-26. doi: 10.1016/j.canlet.2009.04.031. Epub 2009 May 22. Cancer Lett. 2009. PMID: 19464788 Review. - A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS, Roupakia E, Tokamani M, Chavdoula E, Hatziapostolou M, Polytarchou C, Marcu KB, Papavassiliou AG, Sandaltzopoulos R, Kolettas E. Markopoulos GS, et al. Cell Oncol (Dordr). 2017 Aug;40(4):303-339. doi: 10.1007/s13402-017-0341-9. Epub 2017 Jul 26. Cell Oncol (Dordr). 2017. PMID: 28748501 Review. - MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
Fazi F, Blandino G. Fazi F, et al. Microrna. 2013;2(2):81. doi: 10.2174/2211536611302020001. Microrna. 2013. PMID: 25070777
Cited by
- Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells.
Xu D, Tan J, Zhou M, Jiang B, Xie H, Nie X, Xia K, Zhou J. Xu D, et al. Oncol Lett. 2012 Nov;4(5):941-946. doi: 10.3892/ol.2012.878. Epub 2012 Aug 23. Oncol Lett. 2012. PMID: 23162627 Free PMC article. - MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.
Liu J, Chen Z, Xiang J, Gu X. Liu J, et al. Oncol Lett. 2018 Apr;15(4):5561-5568. doi: 10.3892/ol.2018.8069. Epub 2018 Feb 16. Oncol Lett. 2018. PMID: 29556299 Free PMC article. - The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells.
Xu R, Liu T, Zuo L, Guo D, Ye G, Jiang J, Yu X, Zhang S, Hou C. Xu R, et al. Biochem Biophys Rep. 2021 Aug 30;28:101122. doi: 10.1016/j.bbrep.2021.101122. eCollection 2021 Dec. Biochem Biophys Rep. 2021. PMID: 34485716 Free PMC article. - The Positive Effect of MiR1 Antagomir on Ischemic Neurological Disorders Via Changing the Expression of Bcl-w and Bad Genes.
Talebi A, Rahnema M, Bigdeli MR. Talebi A, et al. Basic Clin Neurosci. 2020 Nov-Dec;11(6):811-820. doi: 10.32598/bcn.11.6.324.3. Epub 2020 Nov 1. Basic Clin Neurosci. 2020. PMID: 33850618 Free PMC article. - Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Wickramasinghe NS, et al. Nucleic Acids Res. 2009 May;37(8):2584-95. doi: 10.1093/nar/gkp117. Epub 2009 Mar 5. Nucleic Acids Res. 2009. PMID: 19264808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources